Advertisement
AEMD vs IDXX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEMD is a Hold and IDXX is a StrongBuy.
AEMD's RSI Indicator recovers from overbought zone
The 10-day RSI Indicator for AEMD moved out of overbought territory on October 02, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 instances where the indicator moved out of the overbought zone. In 18 of the 18 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 23 of 27 cases where AEMD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.
The Moving Average Convergence Divergence Histogram (MACD) for AEMD turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 34 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
AEMD broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AEMD entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on AEMD as a result. In 54 of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
Following a +3.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEMD advanced for three days, in 150 of 193 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.786) is normal, around the industry mean (4.170). P/E Ratio (-0.392) is within average values for comparable stocks, (1.500). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (2.111) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. AEMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
IDXX in upward trend: 10-day moving average moved above 50-day moving average on October 21, 2026
The 10-day moving average for IDXX crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 22 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on IDXX as a result. In 58 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
IDXX moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where IDXX advanced for three days, in 178 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Aroon Indicator entered an Uptrend today. In 97 of 171 cases where IDXX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IDXX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
IDXX broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 16 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. IDXX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 67 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 84 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IDXX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (34.127) is normal, around the industry mean (66.911). P/E Ratio (48.816) is within average values for comparable stocks, (2.514). Projected Growth (PEG Ratio) (2.894) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (9.042) is also within normal values, averaging (9.775).
AEMD | IDXX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 19 | 37 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 45 Fair valued | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 84 | |
SMR RATING 1..100 | 99 | 16 | |
PRICE GROWTH RATING 1..100 | 63 | 38 | |
P/E GROWTH RATING 1..100 | 100 | 67 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AEMD's Valuation (45) in the Medical Specialties industry is somewhat better than the same rating for IDXX (86). This means that AEMD’s stock grew somewhat faster than IDXX’s over the last 12 months.
IDXX's Profit vs Risk Rating (84) in the Medical Specialties industry is in the same range as AEMD (100). This means that IDXX’s stock grew similarly to AEMD’s over the last 12 months.
IDXX's SMR Rating (16) in the Medical Specialties industry is significantly better than the same rating for AEMD (99). This means that IDXX’s stock grew significantly faster than AEMD’s over the last 12 months.
IDXX's Price Growth Rating (38) in the Medical Specialties industry is in the same range as AEMD (63). This means that IDXX’s stock grew similarly to AEMD’s over the last 12 months.
IDXX's P/E Growth Rating (67) in the Medical Specialties industry is somewhat better than the same rating for AEMD (100). This means that IDXX’s stock grew somewhat faster than AEMD’s over the last 12 months.
| AEMD | IDXX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 1 day ago 64% |
| Stochastic ODDS (%) | 2 days ago 85% | 1 day ago 71% |
| Momentum ODDS (%) | 2 days ago 76% | 1 day ago 62% |
| MACD ODDS (%) | 2 days ago 90% | N/A |
| TrendWeek ODDS (%) | 2 days ago 77% | 1 day ago 61% |
| TrendMonth ODDS (%) | 2 days ago 90% | 1 day ago 53% |
| Advances ODDS (%) | 16 days ago 78% | 1 day ago 62% |
| Declines ODDS (%) | 3 days ago 90% | 29 days ago 69% |
| BollingerBands ODDS (%) | 2 days ago 90% | 1 day ago 77% |
| Aroon ODDS (%) | 2 days ago 90% | 1 day ago 57% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AEMD’s FA Score shows that 0 FA rating(s) are green while IDXX’s FA Score has 1 green FA rating(s).
- AEMD’s FA Score: 0 green, 5 red.
- IDXX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AEMD’s TA Score shows that 2 TA indicator(s) are bullish while IDXX’s TA Score has 5 bullish TA indicator(s).
- AEMD’s TA Score: 2 bullish, 6 bearish.
- IDXX’s TA Score: 5 bullish, 4 bearish.
Price Growth
AEMD (@Medical/Nursing Services) experienced а +14.40% price change this week, while IDXX (@Medical Specialties) price change was +24.10% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.95%. For the same industry, the average monthly price growth was -3.24%, and the average quarterly price growth was -1.38%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -3.74%. For the same industry, the average monthly price growth was -6.91%, and the average quarterly price growth was +44.46%.
Reported Earning Dates
AEMD is expected to report earnings on Nov 11, 2026.
IDXX is expected to report earnings on Feb 08, 2027.
Industries' Descriptions
@Medical/Nursing Services (+1.95% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Medical Specialties (-3.74% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
Advertisement
AEMD and
Correlation & Price change
A.I.dvisor tells us that AEMD and ISPC have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AEMD and ISPC's prices will move in lockstep.
| Ticker / NAME | Correlation To AEMD | 1D Price Change % | ||
|---|---|---|---|---|
| AEMD | 100% | +9.64% | ||
| ISPC - AEMD | 32% Poorly correlated | -5.12% | ||
| IDXX - AEMD | 25% Poorly correlated | +0.06% | ||
| CSTL - AEMD | 25% Poorly correlated | +0.57% | ||
| MASS - AEMD | 24% Poorly correlated | +4.51% | ||
| IART - AEMD | 24% Poorly correlated | +0.15% | ||
More | ||||